⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8740554 | 0.71 | — | — | |
| Methane SCHEMBL23088734 | 0.00 | — | — | |
| SCHEMBL25396888 | 0.00 | — | — | |
| SCHEMBL23528133 | 0.00 | — | — | |
| SCHEMBL23462191 | 0.00 | — | — | |
| SCHEMBL23462252 | 0.00 | — | — | |
| Hydrogen Sulfide SCHEMBL23805181 | 0.00 | — | — | |
| Water SCHEMBL25436674 | 0.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL25435623 | 0.00 | — | — | |
| SCHEMBL25435013 | 0.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4380982-A1 | PROSTATE CANCER TREATMENT OR TREATMENT OF GYNECOLOGIC OR GENITOURINARY MALIGNANCY WITH A BISPECIFIC ANTIBODY THAT BINDS CTLA4 AND PD1 | Xencor, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023015292-A1 | PROSTATE CANCER TREATMENT OR TREATMENT OF GYNECOLOGIC OR GENITOURINARY MALIGNANCY WITH A BISPECIFIC ANTIBODY THAT BINDS CTLA4 AND PD1 | XENCOR, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-2477478-A1 | A system for transformation of the chloroplast genome of Scenedesmus sp. and Dunaliella sp. | Sapphire Energy, Inc. (US) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011034863-A1 | A SYSTEM FOR TRANSFORMATION OF THE CHLOROPLAST GENOME OF SCENEDESMUS SP. AND DUNALIELLA SP. | SAPPHIRE ENERGY, INC. (US) | 2011-03-24 | — | — | WO | disclosed |
| EP-1644362-A2 | INDOLINONE HYDRAZIDES AS C-MET INHIBITORS | Sugen, Inc. (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005005378-A2 | INDOLINONE HYDRAZIDES AS C-MET INHIBITORS | SUGEN, INC. (US) | 2005-01-20 | — | — | WO | disclosed |